Hyperspectral Imaging in Robot-Assisted Partial Nephrectomy
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this prospective observational study is to learn about the use of a novel imaging technique called hyperspectral imaging in adult participants who are having surgery for removing a tumor from their kidney. Hyperspectral imaging works by shining light on a structure (in this case, the kidney tissue with the tumor) and capturing how it reflects hundreds of very narrow color bands, including ones the human eye can't see. These patterns depend on the composition of the tissue and for example how well blood is flowing through the tissue. By studying these patterns, the investigators want to understand if this technique can be helpful for the surgery where only the part of the kidney with the tumor is removed. The main questions it aims to answer are: * Can hyperspectral imaging show the areas of blood flow in the kidney during surgery? * Is there a connection between the detected patterns of light and the type of kidney tumor? The imaging will happen during the already planned surgery and the participant does not need to undergo any additional tests.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Guz nerki wielkości do 7 cm
- •Planowana operacja usunięcia części nerki przy pomocy robota chirurgicznego
- •Wiek minimum 18 lat
✗ Disqualifies
- •Wcześniejsza operacja na tej samej nerce
- •Guz całkowicie wewnątrz nerki bez części wyrastającej na zewnątrz
- •Poprzedni nowotwór złośliwy leczony chemioterapią szkodliwą dla nerek
- •Obecnie przyjmowane leki osłabiające odporność (np. po przeszczepieniu narządu)
- •Ciąża, karmienie piersią lub chęć posiadania dzieci w przyszłości
- •Brak możliwości wyrażenia świadomej zgody na udział w badaniu
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 3, 2026
- Sex
- No restrictions
Locations (1)
University Hospital Leipzig
Leipzig, Germany
Trial contact
Jens-Uwe Stolzenburg, Professor Dr.
Doreen Trebst, Dr.
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/4/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.